Abstract
The biologically active form of most purine or pyrimidine analogs is the nucleoside 5′-mono, di- or triphosphate. The nucleoside form is most often administered because of the ease with which it penetrates cells by facilitated transport. However, many nucleoside derivatives fail to exhibit significant antiviral or antitumor activity because they are not phosphorylated by cellular enzymes to the active nucleotide form. In this review, the potential use of suitable nucleotide analogs as selective inhibitors of ribonucleotide reductase and viral reverse transcriptase is considered. Masked nucleotides such as phosphoramidates or methyl phosphates could be employed to allow transport across cellular membranes. Furthermore, phosphonocarboxamide, phosphonoformate or sulfamidophosphoramidate may mimic nucleotide di- and triphosphates. Tumor cells and virally infected cells are often more permeable to nucleotides and their analogs than normal cells, which could provide a therapeutic advantage. There could be considerable therapeutic potential for nucleotide analogs that can penetrate the tumor cell membranes and that are resistant to enzymatic hydrolysis and are non-incorporable into DNA or RNA.
Similar content being viewed by others
References
Temin, H. M. (1972) Proc. Natl. Acad. Sci. USA 69, 1016–1020.
Robinson, H. L. (1982) Rev. Infect. Dis. 4, 1015–1025.
Cairns, J. (1981) Nature 289, 353–357.
Poiesz, B. J., Ruscetti, F. N., Reitz, M. S., Kalyanaraman, V. S., Gallo, R. C. (1981) Nature 294, 268–271.
Hinuma, Y., Nagata, K., Hanaoka, M., Nakai, M., Matsumoto, T., Kinoshita, K., Shirakana, S., Miyoshi, I. (1981) Proc. Natl. Acad. Sci. USA 78, 6476–6480.
Blayney, D. W., Jaffe, E. S., Fisher, R. I., Schechter, G. P., Cossman, J., Robert-Guroff, M., Kalyanaraman, V. S., Blattner, W. A., Gallo, C. (1983) Ann. Intern. Med. 98, 144–151; Editorial (1982) Lancet 317–318 Feb. 6.
Kalayanaraman, V. S., Sarngadharan, M. G., Robert-Guroff, J., Miyoshi, I., Blayney, D., Gallo, R. C. (1982) Science 218, 571–573.
Hinuma, Y., Gotoh, Y., Sugamura, K., Nagata, K., Goto, T., Nakai, M., Kamada, N., Matsumoto, T., Kinoshita, K. (1982) Gan. 73, 341–344.
Yoshida, M., Miyoshi, I., Hinuma, Y. (1982) Proc. Natl. Acad. Sci. USA 79, 2031–2035; Yamamoto, N., Okada, M., Koyanagi, Y., Kannagi, M., Hinuma, Y. (1982) Science 217, 737–739.
Essex, M., McLane, M. F., Lee, T. H., Falk, L., Howe, C. W. S., Mullins, J. I., Cabradilla, C., Francis, D. P. (1983) Science 220, 859–862; Gelmann, E. P., Popovic, M., Blayney, D., Masur, H., Sidhu, G., Stahl, R. E., Gallo, R. C. (1983) Science 220, 862–865; Gallo, R. C., Sarin, P. S., Gelmann, E. P., Robert-Guroff, M., Richardson, E., Kalyanaraman, V. S., Mann, D., Sidhu, G. D., Stahl, R. E., Zolla-Pazner, S., Lebowitch, J., Popovic, M. (1983) Science 220, 865–867; Barre-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Bun, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L. (1983) Science 220, 868–871.
Arya, S. K., Job, L., Chawda, R. (1980) Oncology 37, 129–135.
Gallo, R. C., Gelmann, E. P. (1981) N. Engl. J. Med. 304, 169–170.
Chandra, P. (1980) Proc. Fed. Eur. Biochem. Soc. 61, 215–228.
Temin, H. M. (1978) Trends Biochem. Sci. 3, 80–83.
Staal, S. P., Hartley, J. W., Rowe, W. P. (1977) Proc. Natl. Acad, Sci. USA 74, 3065–3067.
Eva, A., Robbins, K., Andersen, P., Srinivasen, A., Papas, T., Tronick, S., Reddy, E. P., Westin, E., Wong-Staal, F., Gallo, R., Ellmore, N., Aarronson, S., (1981) Abstracts of papers presented at the Cold Spring Harbor meeting on “RNA Tumor Viruses”, on May 20–24, p. 294.
Varmus, H. E. (1982) Science 216, 812–820.
Robinson, W. S., Robinson, H. L. (1971) Virology 44, 457.
Murphy, E. C. (1981) Abstracts of papers presented at the Cold Spring Harbor meeting on “RNA-Tumor Viruses” on May 20–24, p. 86.
Gerwin, B. I., Rein, A., Levin, J. G., Bassin, R. H., Benjers, B. M., Kashmira, S. V. S., Hopkins, D., O'Neill, B. J. (1979) Virology 31, 741–751.
For a review, see Chandra, P., Steel, L. K., Ebener, U., Woltersdorf, M., Laube, H., Kornhuber, B., Mildner, B., Goetz, A. (1977) Pharmacol. Ther. 1, 231–287.
Summers, J., Mason, W. S. (1982) Cell 29, 403–415.
Marx, J. L. (1982) Science 217, 1021–1022.
Zuckerman, A. J. (1980) Nature 287, 483–484.
Beasley, R. P., Lin, C. C., Hwang, L. Y., Chien, C. S. (1981) Lancet 1129–1133.
Aaronson, S. A. (1983) Cancer Res. 43, 1–5.
Auld, D. A., Kawaguchi, H., Livingston, D. M., Vallee, B. L. (1974) Proc. Natl. Acad. Sci. USA 71, 2091–2095.
Batula, N., Loeb, L. A. (1976) J. Biol. Chem. 251, 982–986.
Molling, K., Plassmann, H. W., Bolognesi, D. P., Hausen, P., Bauer, H., Busen, W. (1971) Nature New Biol. 234, 240–243.
Pitha, P. M., Pitha, J. (1978) Pharmacol. Ther. A 2, 247–260.
Fry, M., Weissbach, A. (1973) J. Biol. Chem. 248, 2678–2683.
Ross, J., Scolnick, E. M., Todaro, G. J., Aaronson, S. A. (1971) Nature New Biol. 231, 163–167.
Ting, T. C., Yang, S. S., Gallo, R. C. (1972) Nature New Biol. 236, 163–166.
Wu, A. M., Ting, R. C., Gallo, R. C. (1973) Proc. Natl. Acad. Sci. USA 70, 1298–1302.
Schabel, F. M., Jr. (1975) Cancer Chemother. Rep. (Part 1) 59, 261–265.
Shannon, W. M., Schabel, Frank M., Jr. (1980) Pharmacol. Ther. 11, 263–390.
Baltimore, D. (1970) Nature 226, 1209–1211.
Temin, H. M., Mizutani, S. (1970) Nature 226, 1211–1213.
Bishop, J. M. (1980) N. Engl. J. Med. 303, 675–682.
Temin, H. M., Mizutani, S. (1970) Nature 226, 1211–1213.
Eriksson, B., Stening, G., Oberg, B. (1982) Antiviral Res. 2, 81–95.
Kiselev, L. L., Englegardt, V. A. (1979) Mol. Biol. 13, 245–266 Russian, 179–196 English.
Kit, S. (1979) Pharmacol. Ther. 4, 501–585.
Verma, I. M. (1977) Biochim. Biophys. Acta 473, 1–38.
Varmus, H. E. (1982) Science 216, 812–820.
Bekesi, J. G., Roboz, J. P., Zimmerman, E., Holland, J. H. (1976) Cancer Res. 36, 631–639.
As quoted in (1977) Ann. N. Y. Acad. Sci. 284, 585–590 by Jolley, W. B., Chu, W. T., Slater, J. M., Hinshaw, D. B., Rondhawa, A. S.
Shannon, W. M. (1977) Ann. N. Y. Acad. Sci. 284, 472–507.
Jolley, W. B., Chu, W. T., Slater, J. M., Hinshaw, D. B., Rondhawa, A. S. (1977) Ann. N. Y. Acad. Sci. 284, 585–590.
Khwaja, T. A., Popovic, M. R., Witkowski, J. T., Robins, R. K., Halpern, R. M., Smith, R. A. (1972) Proc. Am. Assoc. Cancer Res. 13, 91.
Newman, H., Vodenlich, L., Potter, C. W. (1977) Eur. J. Cancer 13, 821–830.
Jenkins, F. J., Chen, Y. C. (1981) Antimicrob. Agents Chemother. 19, 364–368.
Witkowski, J. T., Robins, R. K., Sidwell, R. W., Simon, L. N. (1972) J. Med. Chem. 15, 1150–1154.
Sidwell, R. W., Huffman, J. H., Khare, G. P., Allen, L. B., Witkowski, J. T., Robins, R. K. (1972) Science 177, 705–706.
Willis, R. C., Carson, D. A., Seegmiller, J. E. (1978) Proc. Natl. Acad. Sci. USA 75, 3042–3044.
Streeter, D. G., Simon, L. N., Robins, R. K., Miller, J. P. (1974) Biochemistry 13, 4543–4549.
Zimmerman, T. P., Deeprose, R. D. (1978) Biochem. Pharmacol. 27, 709–716.
Tuominen, F. W., Kenney, F. T. (1972) Biochem. Biophys. Res. Commun. 48, 1469–1475.
Muller, W. E. G., Yamazaki, Z., Sogtrop, H. H., Zahn, R. K. (1972) Eur. J. Cancer 8, 421–428.
Schrecker, A. W., Smith, R. G., Gallo, R. C. (1974) Cancer Res. 34, 286.
Smoler, D., Mollineux, I., Baltimore, D. (1971) J. Biol. Chem. 246, 7697–7700.
Faras, A. J., Taylor, J. M., Levinson, W. E. Goodman, W. E., Bishop, J. M. (1973) J. Mol. Biol. 79, 163–183.
Byars, N., Kidson, C. (1975) Biochemistry 14, 3159–3164.
Furmanski, P., Bourguignon, G. J., Bolles, C. S., Corombos, J. D., Das, M. R. (1980) Cancer Lett. 8, 307–315.
van der Vliet, P. C., Kwant, M. M. (1981) Biochemistry 20, 2628–2632.
Brinkley, S. A., Lewis, A., Critz, W. J., Witt, L. L., Townsend, L. B., Blakley, R. L. (1978) Biochemistry 17, 2350–2356.
Cory, J. G., Whitford, T. W., Jr. (1972) Cancer Res. 32, 1301–1306.
Elford, H. L., Freese, M., Passamani, E., Morris, H. P. (1970) J. Biol. Chem. 245, 5228–5233.
Weber, G. (1977) N. Engl. J. Med. 296, 486–493.
Weber, G., Olah, E., Lui, M. S., Kizaki, H., Tzeng, D. Y., Takeda, E. (1980) Adv. Enzyme Reg. 18, 3–26.
Weber, G., Prajda, N., Williams, J. C. (1975) Adv. Enzyme Reg. 13, 3–23.
Young, C. W., Hodas, S. (1964) Science 146, 1172–1174.
Dove, C., Paul, M. A., Rustum, Y. M. (1978) Eur. J. Cancer 14, 33–40.
Booth, B. A., Argawal, K. C., Moore, E. C., Sartorelli, A. C. (1974) Cancer Res. 34, 1308–1314.
Cory, J. G., Mansell, M. M., Whitford, T. W. Jr. (1976) Adv. Enzyme Reg. 14, 45–62.
Lewis, W. H., McNaughton, D. R., Goh, S. H., LeJohn, H. B., Wright, J. A. (1978) J. Cell. Physiol. 93, 345–352.
McNaughton, D. R., Klassen, G. R., Loewen, P. C., LeJohn, H. B. (1978) Can. J. Biochem. 56, 217–226.
Lapi, L., Cohen, S. S. (1977) Biochem. Pharmacol. 26, 71–76.
Fujioka, S., Silber, R. (1970) J. Biol. Chem. 245, 1688–1693.
Kummer, D., Kraml, F., Heitland, W., Jacob, E. (1978) Z. Krebsforsch. 91, 23–34.
Reichard, P. (1978) Fed. Proc. Fed. Am. Soc. Exp. Biol. 37, 9–14.
Elford, H. L., Bonner, E. L., Kerr, B. H., Hanna, S. D., Smulson, M. (1977) Cancer Res. 37, 4389–4394.
Ullman, B., Gudas, L. J., Clift, S. M., Martin, D. W., Jr. (1979) Proc. Natl. Acad. Sci. USA 76, 1074–1078.
Chang, C. H., Cheng, Y. C. (1980) Cancer Res. 40, 3555–3558.
Ludwig, W., Follman, H. (1978) Eur. J. Biochem. 91, 493–499.
Thelander, L., Reichard, P. (1979) Ann. Rev. Biochem. 48, 133–158.
Hunting, D., Henderson, J. F. (1982) CRC Crit. Rev. Biochem. 13, 325–348.
Chabner, B. A., Myers, C. E., Coleman, N., Johns, D. G. (1975) N. Engl. J. Med. 292, 1159–1168.
Bloch, A. A. (1973) in Drug Design, pp. 286–378, Academic Press, N.Y.
Montgomery, J. A. (1982) Med. Res. Rev. 2, 271–308.
Montgomery, J. A. (1970) Prog. Med. Chem. 7, 70–103.
Bloch, A. (1975) Ann. N. Y. Acad. Sci. 255, 576–596.
Brockmann, R. W. Handbuch der Experimentellen Pharmakologie (part 1) 38, pp. 369, Springer-Verlag, Berlin.
Plagemann, P. G. W., Wohlhueter, R. M. (1980) Curr. Top. Membr. Transp. 14, 225–330.
LePage, G. A., Naik, S. (1975) Ann. N. Y. Acad. Sci. 225, 481–488.
Cohen, S. S., Plunkett, W. (1975) Ann. N. Y. Acad. Sci. 255, 269–286.
Plunkett, W., Lapi, L., Ortiz, P. M., Cohen, S. S. (1974) Proc. Natl. Acad. Sci. USA 71, 73–77.
LePage, G. A., Naik, S. R., Katakkar, S. B., Khaliz, A. (1975) Cancer Res. 35, 3036–3040.
Plunkett, W., Cohen, S. S. (1975) Cancer Res. 35, 1547–1554.
Berlin, R. D., Oliver, J. M. (1975) Int. Rev. Cytol. 42, 287–336.
Hochstadt, J. (1974) Crit. Rev. Biochem. 2, 259–310.
Fleit, H., Conklyn, M., Stebbins, R. D., Silver, R. (1975) J. Biol. Chem. 250, 8889–8892.
Harms, V., Sterling, C. E. (1977) Ann. J. Physiol. 233, E47–E55.
Sirotnak, F. M., Chello, P. L., Brockman, R. W. (1979) Methods Cancer Res. 16, 381–447.
Rozengurt, E., Heppel, L. A. (1975) Biochem. Biophys. Res. Commun. 67, 1581–1588.
Broucek, J., Zavadova, J., Voma, V. (1979) Intervirology 11, 58–60.
Rozengurt, E., Heppel, L. A., Friedberg, I. (1977) J. Biol. Chem. 252, 4584–4590; Rozengurt, E., Heppel, L. A. (1979) J. Biol. Chem. 254, 708–714.
Landry, Y., Lehninger, A. L. (1976) J. Biochem. 158, 427–438.
Makan, N. R. (1978) Exp. Cell Res. 114, 417–427.
Kitagawa, T. (1980) J. Cell. Physiol. 102, 37–43.
Makan, N. R. (1979) J. Cell. Physiol. 101, 481–492.
Stillwell, W., Winter, H. C. (1974) Biochem. Biophys. Res. Commun. 56, 617–622.
Schlimme, E., Boos, K. S., Bojanovski, D., Lustorff, J. (1977) Angew. Chem. (Eng. Ed.) 16, 695–702.
Castellot, J. J., Jr., Miller, M. R., Pardee, A. B. (1978) Proc. Natl. Acad. Sci. USA 75, 351–355.
Sheridan, J. D., Finbow, M. E., Pitts, J. D. (1979) Exp. Cell. Res. 123, 111–117.
Sheridan, W. F. (1975) J. Cell. Biol. 67, A396.
Weinstein, R. S., Merk, F. B., Alroy, J. (1976) Adv. Cancer Res. 23, 23–89.
Flagg-Newton, J. L. (1980) In Vitro 16, 1043–1048.
Contreras, A., Carrasco, L. (1979) J. Virology 29, 114–122.
Carrasco, L. (1978) Nature 272, 694–699.
Fernandez-Puentes, C., Carrasco, L. (1980) Cell 20, 769–775.
Lacal, J. C., Vasquez, D., Fernandez-Sousa, J. M., Carrasco, L. (1980) J. Antibiot. 33 441–446.
Carrasco, L., Smith, A. E. (1980) Pharmacol. Ther. 9, 311–355.
Kucera, R., Paulus, H. (1982) Arch. Biochem. Biophys. 214, 102–113.
Kucera, R., Paulus, H. (1982) Arch. Biochem. Biophys. 214, 114–123.
Revankar, G. R., Huffman, J. H., Allen, L. B., Sidwell, R. W., Robins, R. K., Tolman, R. L. (1975) J. Med. Chem. 18, 721–726.
Cass, C. E., Tan, T. H., Selner, M. (1979) Cancer Res. 39, 1563–1569.
Baker, B. R., Sachdev, H. S. (1963) J. Pharm. Sci. 52, 933–940.
Baker, B. R., Chheda, G. (1965) J. Pharm. Sci. 54, 25–30.
Baker, B. R., Tanna, P. M. (1965) J. Pharm. Sci. 54, 845–848.
Baker, B. R., Tanna, P. M., Jackson, G. D. F. (1965) J. Pharm. Sci. 54, 987–994.
Baker, B. R., Tanna, P. M. (1965) J. Pharm. Sci. 54, 1609–1616.
Baker, B. R., Jackson, G. D. F., Chheda, G. B. (1965) J. Pharm. Sci. 54, 1617–1620.
Baker, B. R., Tanna, P. M. (1965) J. Pharm. Sci. 54, 1774–1781.
Shuman, D. A., Robins, M. J., Robins, R. K. (1970) J. Am. Chem. Soc. 92, 3434–3440.
Jaffe, J. J., McCormack, J. J., Meymerian, E. (1970) Exp. Parasitol. 28, 535–543.
Bloch, A., Coutsogeorgopoulos, C. (1971) Biochemistry 19, 4394–4398.
Mungall, W. S., Lemmen, L. J., Lemmen, K. L., Dethmers, J. K., Norling, L. L. (1978) J. Med. Chem. 21, 704–706.
Phelps, M. E., Woodman, P. S., Danenberg, P. V. (1980) J. Med. Chem. 23, 1229–1232.
Hampton, A., Sasaki, T., Paul, B. (1973) J. Am. Chem. Soc. 95, 4404–4414.
Hampton, A., Perini, F., Harper, P. J. (1973) Biochemistry 12, 1730–1736.
Margalith, M., Falk, H., Panet, A. (1982) Mol. Cell. Biochem. 43, 97–103.
Sundquist, B., Oberg, B. (1979) J. Gen. Virol. 45, 273–281.
Eriksson, B., Oberg, B., Wahren, B. (1982) Biochim, Biophys. Acta 696, 115–123.
Eriksson, B., Stening, G., Oberg, B. (1982) Antiviral Res. 2, 81–95.
Monir-Vaghefi, S. M., Robins, R. K. (unpublished results).
Richardson, J. P. (1975) Angew. Chem. Int. Ed. Eng. 14, 445–452.
Remy, P., Dirheimer, G., Ebel, J. P. (1967) Biochim. Biophys. Acta 136, 99–107.
Remy, P., Engel, M. L., Dirheimer, G., Ebel, J. P., Revel, M. (1970) J. Mol. Biol. 48, 173–176.
Azhayev, A. V., Krayensky, A. A., Smrt, J. (1979) Collect. Czech. Chem. Commun. 44, 792–798.
Simoncsits, A., Tomasz, J. (1976) Tet. Lett. 3995–3998.
Myers, T. C., Nakamura, K., Flesher, J. W. (1963) J. Am. Chem. Soc. 85, 3292–3295.
Yount, R. G., Babcock, D., Ojala, D., Ballantyne, W. (1971) Biochemistry 10, 2484–2489.
Yount, R. G., Ojala, D., Babcock, D. (1971) Biochemistry 10, 2490–2496.
Yount, R. G. (1975) Adv. Enzymol. 43, 1–56.
Sundaralingam, M. (1969) Biopolymers 7, 821–860.
Shen, T. Y. (1970) Angew. Chem. Int. Ed. Eng. 9, 678–688.
Rights and permissions
About this article
Cite this article
Robins, R.K. The Potential of Nucleotide Analogs as Inhibitors of Retroviruses and Tumors. Pharm Res 1, 11–18 (1984). https://doi.org/10.1023/A:1016370407633
Issue Date:
DOI: https://doi.org/10.1023/A:1016370407633